Table 1. Clinical characterization of... | American Society of Hematology

Table 1.

Clinical characterization of patients

	Age, y/sex		Duration, y	Before IVIG, muscle involvement			Before IVIG, skin involvement			IVIG cycles	Final outcome, muscle involvement			Final outcome, skin involvement
Patient	Age, y/sex		Duration, y	Diagnosis		Score*	CK level	Extent†	Pruritus‡	IVIG cycles		Score*	CK level	Extent†	Pruritus‡
A	34/F	ADM	5	60	57	+	+++	2 × 2	60	51	0	+
B	16/F	ADM	10	60	82	+	0	1 × 2	60	101	+	0
G	50/F	ADM	14	60	56	+	+++	1 × 2	60	64	+	++
F	35/M	DM	3	52	302	++	++	2 × 2	57	103	+	0
H	40/F	DM	2	34	1140	++	+	7 × 2	34	344	+	0
I	71/F	DM	< 1	25	1620	++	++	4 × 1	51	46	+	++
K	54/M	DM	3	46	343	+	0	4 × 1	45	283	0	0
L	53/F	DM	< 1	54	490	++	+	4 × 2	57	65	++	+

	Age, y/sex		Duration, y	Before IVIG, muscle involvement			Before IVIG, skin involvement			IVIG cycles	Final outcome, muscle involvement			Final outcome, skin involvement
Patient	Age, y/sex		Duration, y	Diagnosis		Score*	CK level	Extent†	Pruritus‡	IVIG cycles		Score*	CK level	Extent†	Pruritus‡
A	34/F	ADM	5	60	57	+	+++	2 × 2	60	51	0	+
B	16/F	ADM	10	60	82	+	0	1 × 2	60	101	+	0
G	50/F	ADM	14	60	56	+	+++	1 × 2	60	64	+	++
F	35/M	DM	3	52	302	++	++	2 × 2	57	103	+	0
H	40/F	DM	2	34	1140	++	+	7 × 2	34	344	+	0
I	71/F	DM	< 1	25	1620	++	++	4 × 1	51	46	+	++
K	54/M	DM	3	46	343	+	0	4 × 1	45	283	0	0
L	53/F	DM	< 1	54	490	++	+	4 × 2	57	65	++	+

Score determined according to Dalakas et al.²⁵

0 = none; + = localized; ++ = extensive.

0 = none; + = slight; ++ = moderate; +++ = severe.